00876.HK
Kaisa Health Group Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · HK
HKD 1.96
−2.00%Aug 20, 2026, 02:10 UTC
Kaisa Health Group issued a profit warning, expecting its loss attributable to owners for the six months ended June 2026 to widen to no more than HK$65 million, compared with a restated loss of about HK$7.7 million in the same period last year.
Source:Jul 27, 2026, 14:22 UTC
Kaisa Health's subsidiary Qinghai Pharmaceutical obtained a drug registration certificate for Hydromorphone Hydrochloride Injection, becoming one of only three enterprises nationwide holding a valid production registration certificate for this product.
Source: